Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Shubhashri Mohire"'
Autor:
Shubhashri Mohire, K. Elango, Mahesh Thondawada, Karthik Yamjala, Vishakantha Murthy, Nilesh Sudhakar Ambhore, Shashank Mulukutla, Rama Satyanarayana Raju Kalidhindi
Publikováno v:
Journal of Young Pharmacists. 12:55-62
Objectives: Epidemiological data suggests the highest density of histamine H3-receptors (H3R) in basal ganglia of central nervous system (CNS) wherein they function as inhibitory auto-receptors and control the release of many neurotransmitters. Inhib
Autor:
Nilesh Sudhakar, Ambhore, Kalidhindi Rama, Satyanarayana Raju, Shashank, Mulukutla, Karthik, Yamjala, Shubhashri, Mohire, Veera Venkata, Satyanarayana Reddy Karri, Saurabh, Gupta, Vishakantha, Murthy, Kannan, Elango
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
The major challenge to treat Parkinson’s disease (PD) is penetration of target molecule into the brain to improve the efficacy of drugs. To achieve better brain penetration and targeted delivery, 1,9-Pyrazoloanthrone (1,9-P) loaded liposomes were d
Autor:
Shubhashri Mohire, Shashank Mulukutla, Mahesh Tondhawada, Karthik Yamjala, Vishakantha Murthy, Nilesh Sudhakar Ambhore, K. Elango, Kalidhindi Rama Satyanarayana Raju
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 120
JNK pathway activates c-Jun(s) which are responsible for cell apoptosis; as a result, inhibitors of JNK pathway have the potential to prevent dopaminergic neurons from death and decrease the loss of dopamine in substantia nigra pars compacta (SNpc).
H-3 Receptor Antagonist and JNK-3 Inhibitor: A new therapeutic approach to treat Parkinson’s disease
Autor:
Shubhashri Mohire, Ramasatyanarayana Raju Kalidindi, Elango Kannan, Shashank Mulukutala, Vishakantha Murthy, Nilesh Sudhakar Ambhore
Publikováno v:
Parkinsonism & Related Disorders. 22:e91